MOISES R FAJARDO
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner TROY, MI NPI 1740683069
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner MI NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$8,844.28
- Category: General Payments
- Program years: PY2021–2024
- Record count: 113
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $4,048.05 across 40 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $3,051.05 | 30 |
| Long term medical supply or device loan | $997.00 | 10 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $1,018.06 | 11 |
| Amgen Inc. | $427.41 | 4 |
| Gilead Sciences, Inc. | $261.30 | 3 |
| Teva Pharmaceuticals USA, Inc. | $244.44 | 2 |
| Alexion Pharmaceuticals, Inc. | $239.40 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $210.87 | 2 |
| ACADIA Pharmaceuticals Inc | $191.84 | 3 |
| Medtronic, Inc. | $144.00 | 1 |
| ABIOMED | $139.14 | 1 |
| Janssen Biotech, Inc. | $124.74 | 1 |
| Otsuka America Pharmaceutical, Inc. | $124.74 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $123.75 | 1 |
| Lilly USA, LLC | $121.86 | 1 |
| Actelion Pharmaceuticals US, Inc. | $121.35 | 1 |
| Merck Sharp & Dohme Corporation | $112.37 | 1 |
| ViiV Healthcare Company | $107.10 | 1 |
| EISAI INC. | $103.28 | 1 |
| Janssen Scientific Affairs, LLC | $91.48 | 1 |
| Amarin Pharma Inc. | $90.92 | 1 |
| BeiGene USA, Inc. | $50.00 | 1 |
By program year
Records — PY2024 (40)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.